 | • レポートコード：GIR-107A14450 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、トポテカンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。トポテカンの種類別市場規模（カプセル、注射）、用途別市場規模（卵巣がん、肺がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・トポテカンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GSK、Teva、Fresenius Kabi、Cipla、Sagent Pharmaceuticals、Mylan、Pfizer、Dr. Reddy's Laboratories ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：カプセル、注射 ・用途別分析2016年-2026年：卵巣がん、肺がん、その他 ・トポテカンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・トポテカンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・トポテカンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・トポテカンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・トポテカンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Topotecan market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Topotecan size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Topotecan market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Topotecan market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Capsules
Injection
Market segment by Application, can be divided into
Ovarian Cancer
Lung Cancer
Other Cancer types
Market segment by players, this report covers
GSK
Teva
Fresenius Kabi
Cipla
Sagent Pharmaceuticals
Mylan
Pfizer
Dr. Reddy’s Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Topotecan
1.2 Classification of Topotecan by Type
1.2.1 Overview: Global Topotecan Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Topotecan Revenue Market Share by Type in 2020
1.2.3 Capsules
1.2.4 Injection
1.3 Global Topotecan Market by Application
1.3.1 Overview: Global Topotecan Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Ovarian Cancer
1.3.3 Lung Cancer
1.3.4 Other Cancer types
1.4 Global Topotecan Market Size & Forecast
1.5 Global Topotecan Market Size and Forecast by Region
1.5.1 Global Topotecan Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Topotecan Market Size by Region, (2016-2021)
1.5.3 North America Topotecan Market Size and Prospect (2016-2026)
1.5.4 Europe Topotecan Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Topotecan Market Size and Prospect (2016-2026)
1.5.6 South America Topotecan Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Topotecan Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Topotecan Market Drivers
1.6.2 Topotecan Market Restraints
1.6.3 Topotecan Trends Analysis
2 Company Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Topotecan Product and Solutions
2.1.4 GSK Topotecan Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 GSK Recent Developments and Future Plans
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Topotecan Product and Solutions
2.2.4 Teva Topotecan Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Teva Recent Developments and Future Plans
2.3 Fresenius Kabi
2.3.1 Fresenius Kabi Details
2.3.2 Fresenius Kabi Major Business
2.3.3 Fresenius Kabi Topotecan Product and Solutions
2.3.4 Fresenius Kabi Topotecan Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Fresenius Kabi Recent Developments and Future Plans
2.4 Cipla
2.4.1 Cipla Details
2.4.2 Cipla Major Business
2.4.3 Cipla Topotecan Product and Solutions
2.4.4 Cipla Topotecan Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Cipla Recent Developments and Future Plans
2.5 Sagent Pharmaceuticals
2.5.1 Sagent Pharmaceuticals Details
2.5.2 Sagent Pharmaceuticals Major Business
2.5.3 Sagent Pharmaceuticals Topotecan Product and Solutions
2.5.4 Sagent Pharmaceuticals Topotecan Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Sagent Pharmaceuticals Recent Developments and Future Plans
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business
2.6.3 Mylan Topotecan Product and Solutions
2.6.4 Mylan Topotecan Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Mylan Recent Developments and Future Plans
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Topotecan Product and Solutions
2.7.4 Pfizer Topotecan Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Pfizer Recent Developments and Future Plans
2.8 Dr. Reddy’s Laboratories
2.8.1 Dr. Reddy’s Laboratories Details
2.8.2 Dr. Reddy’s Laboratories Major Business
2.8.3 Dr. Reddy’s Laboratories Topotecan Product and Solutions
2.8.4 Dr. Reddy’s Laboratories Topotecan Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Dr. Reddy’s Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Topotecan Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Topotecan Players Market Share
3.2.2 Top 10 Topotecan Players Market Share
3.2.3 Market Competition Trend
3.3 Topotecan Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Topotecan Revenue and Market Share by Type (2016-2021)
4.2 Global Topotecan Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Topotecan Revenue Market Share by Application (2016-2021)
5.2 Topotecan Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Topotecan Revenue by Type (2016-2026)
6.2 North America Topotecan Revenue by Application (2016-2026)
6.3 North America Topotecan Market Size by Country
6.3.1 North America Topotecan Revenue by Country (2016-2026)
6.3.2 United States Topotecan Market Size and Forecast (2016-2026)
6.3.3 Canada Topotecan Market Size and Forecast (2016-2026)
6.3.4 Mexico Topotecan Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Topotecan Revenue by Type (2016-2026)
7.2 Europe Topotecan Revenue by Application (2016-2026)
7.3 Europe Topotecan Market Size by Country
7.3.1 Europe Topotecan Revenue by Country (2016-2026)
7.3.2 Germany Topotecan Market Size and Forecast (2016-2026)
7.3.3 France Topotecan Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Topotecan Market Size and Forecast (2016-2026)
7.3.5 Russia Topotecan Market Size and Forecast (2016-2026)
7.3.6 Italy Topotecan Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Topotecan Revenue by Type (2016-2026)
8.2 Asia-Pacific Topotecan Revenue by Application (2016-2026)
8.3 Asia-Pacific Topotecan Market Size by Region
8.3.1 Asia-Pacific Topotecan Revenue by Region (2016-2026)
8.3.2 China Topotecan Market Size and Forecast (2016-2026)
8.3.3 Japan Topotecan Market Size and Forecast (2016-2026)
8.3.4 South Korea Topotecan Market Size and Forecast (2016-2026)
8.3.5 India Topotecan Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Topotecan Market Size and Forecast (2016-2026)
8.3.7 Australia Topotecan Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Topotecan Revenue by Type (2016-2026)
9.2 South America Topotecan Revenue by Application (2016-2026)
9.3 South America Topotecan Market Size by Country
9.3.1 South America Topotecan Revenue by Country (2016-2026)
9.3.2 Brazil Topotecan Market Size and Forecast (2016-2026)
9.3.3 Argentina Topotecan Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Topotecan Revenue by Type (2016-2026)
10.2 Middle East & Africa Topotecan Revenue by Application (2016-2026)
10.3 Middle East & Africa Topotecan Market Size by Country
10.3.1 Middle East & Africa Topotecan Revenue by Country (2016-2026)
10.3.2 Turkey Topotecan Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Topotecan Market Size and Forecast (2016-2026)
10.3.4 UAE Topotecan Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Topotecan Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Topotecan Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Topotecan Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Topotecan Revenue (USD Million) by Region (2016-2021)
Table 5. Global Topotecan Revenue Market Share by Region (2021-2026)
Table 6. GSK Corporate Information, Head Office, and Major Competitors
Table 7. GSK Major Business
Table 8. GSK Topotecan Product and Solutions
Table 9. GSK Topotecan Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Teva Corporate Information, Head Office, and Major Competitors
Table 11. Teva Major Business
Table 12. Teva Topotecan Product and Solutions
Table 13. Teva Topotecan Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Fresenius Kabi Corporate Information, Head Office, and Major Competitors
Table 15. Fresenius Kabi Major Business
Table 16. Fresenius Kabi Topotecan Product and Solutions
Table 17. Fresenius Kabi Topotecan Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Cipla Corporate Information, Head Office, and Major Competitors
Table 19. Cipla Major Business
Table 20. Cipla Topotecan Product and Solutions
Table 21. Cipla Topotecan Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Sagent Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Sagent Pharmaceuticals Major Business
Table 24. Sagent Pharmaceuticals Topotecan Product and Solutions
Table 25. Sagent Pharmaceuticals Topotecan Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Mylan Corporate Information, Head Office, and Major Competitors
Table 27. Mylan Major Business
Table 28. Mylan Topotecan Product and Solutions
Table 29. Mylan Topotecan Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Pfizer Corporate Information, Head Office, and Major Competitors
Table 31. Pfizer Major Business
Table 32. Pfizer Topotecan Product and Solutions
Table 33. Pfizer Topotecan Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Dr. Reddy's Laboratories Corporate Information, Head Office, and Major Competitors
Table 35. Dr. Reddy's Laboratories Major Business
Table 36. Dr. Reddy's Laboratories Topotecan Product and Solutions
Table 37. Dr. Reddy's Laboratories Topotecan Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Topotecan Revenue (USD Million) by Players (2019-2021)
Table 39. Global Topotecan Revenue Share by Players (2019-2021)
Table 40. Breakdown of Topotecan by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Topotecan Players Head Office, Products and Services Provided
Table 42. Topotecan Mergers & Acquisitions in the Past Five Years
Table 43. Topotecan New Entrants and Expansion Plans
Table 44. Global Topotecan Revenue (USD Million) by Type (2016-2021)
Table 45. Global Topotecan Revenue Share by Type (2016-2021)
Table 46. Global Topotecan Revenue Forecast by Type (2021-2026)
Table 47. Global Topotecan Revenue by Application (2016-2021)
Table 48. Global Topotecan Revenue Forecast by Application (2021-2026)
Table 49. North America Topotecan Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Topotecan Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Topotecan Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Topotecan Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Topotecan Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Topotecan Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Topotecan Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Topotecan Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Topotecan Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Topotecan Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Topotecan Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Topotecan Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Topotecan Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Topotecan Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Topotecan Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Topotecan Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Topotecan Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Topotecan Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Topotecan Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Topotecan Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Topotecan Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Topotecan Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Topotecan Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Topotecan Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Topotecan Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Topotecan Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Topotecan Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Topotecan Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Topotecan Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Topotecan Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Topotecan Picture
Figure 2. Global Topotecan Revenue Market Share by Type in 2020
Figure 3. Capsules
Figure 4. Injection
Figure 5. Topotecan Revenue Market Share by Application in 2020
Figure 6. Ovarian Cancer Picture
Figure 7. Lung Cancer Picture
Figure 8. Other Cancer types Picture
Figure 9. Global Topotecan Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Topotecan Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Topotecan Revenue Market Share by Region (2016-2026)
Figure 12. Global Topotecan Revenue Market Share by Region in 2020
Figure 13. North America Topotecan Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Topotecan Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Topotecan Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Topotecan Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Topotecan Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Topotecan Market Drivers
Figure 19. Topotecan Market Restraints
Figure 20. Topotecan Market Trends
Figure 21. GSK Recent Developments and Future Plans
Figure 22. Teva Recent Developments and Future Plans
Figure 23. Fresenius Kabi Recent Developments and Future Plans
Figure 24. Cipla Recent Developments and Future Plans
Figure 25. Sagent Pharmaceuticals Recent Developments and Future Plans
Figure 26. Mylan Recent Developments and Future Plans
Figure 27. Pfizer Recent Developments and Future Plans
Figure 28. Dr. Reddy's Laboratories Recent Developments and Future Plans
Figure 29. Global Topotecan Revenue Share by Players in 2020
Figure 30. Topotecan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 31. Global Top 3 Players Topotecan Revenue Market Share in 2020
Figure 32. Global Top 10 Players Topotecan Revenue Market Share in 2020
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 34. Global Topotecan Revenue Share by Type in 2020
Figure 35. Global Topotecan Market Share Forecast by Type (2021-2026)
Figure 36. Global Topotecan Revenue Share by Application in 2020
Figure 37. Global Topotecan Market Share Forecast by Application (2021-2026)
Figure 38. North America Topotecan Sales Market Share by Type (2016-2026)
Figure 39. North America Topotecan Sales Market Share by Application (2016-2026)
Figure 40. North America Topotecan Revenue Market Share by Country (2016-2026)
Figure 41. United States Topotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Topotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Topotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Topotecan Sales Market Share by Type (2016-2026)
Figure 45. Europe Topotecan Sales Market Share by Application (2016-2026)
Figure 46. Europe Topotecan Revenue Market Share by Country (2016-2026)
Figure 47. Germany Topotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Topotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Topotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Topotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Topotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Topotecan Sales Market Share by Type (2016-2026)
Figure 53. Asia-Pacific Topotecan Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Topotecan Revenue Market Share by Region (2016-2026)
Figure 55. China Topotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Topotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South Korea Topotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Topotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Topotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Topotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Topotecan Sales Market Share by Type (2016-2026)
Figure 62. South America Topotecan Sales Market Share by Application (2016-2026)
Figure 63. South America Topotecan Revenue Market Share by Country (2016-2026)
Figure 64. Brazil Topotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Argentina Topotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Middle East and Africa Topotecan Sales Market Share by Type (2016-2026)
Figure 67. Middle East and Africa Topotecan Sales Market Share by Application (2016-2026)
Figure 68. Middle East and Africa Topotecan Revenue Market Share by Country (2016-2026)
Figure 69. Turkey Topotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Saudi Arabia Topotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. UAE Topotecan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source
世界のトポテカン市場予測（～2024年） Topotecan (trade name Hycamtin) is a chemotherapeutic agent that is a topoisomerase inhibitor. It is a synthetic, water-soluble analog of the natural chemical compound camptothecin. It is used in the form of its hydrochloride salt to treat ovarian cancer, lung cancer and other cancer types. Scope of…- 世界の卵巣がん診断技術市場 2021：企業別、地域別、種類・用途別 The Ovarian Cancer Diagnostics Technologies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界の卵巣がん治療・診断市場 2021：企業別、地域別、種類・用途別 The Therapies and Diagnostics for Ovarian Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 世界の上皮性卵巣がん治療市場 2021：企業別、地域別、種類・用途別 The Epithelial Ovarian Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界の肺がん診断市場 2021：企業別、地域別、種類・用途別 The Lung Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…